Non-Invasive Prenatal Testing (NIPT) Market, By Product Type (Devices, Consumables, and Others), By Techniques (cfDNA, Biochemical Screening Tests, and Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, and Others), By End-User (Diagnostic Laboratories, Hospitals, and Cell DNA screening), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2030

Report Code: PMI451920 | Publish Date: September 2022 | No. of Pages: 168

Global Non Invasive Prenatal Testing (NIPT) Market Overview

A Non-Invasive Prenatal Testing (NIPT) is a screening test to identify if the unborn child/fetus is at risk for a Noninvasive prenatal testing (NIPT), sometimes called noninvasive prenatal screening (NIPS), is a method of determining the risk of a fetus being born with certain genetic abnormalities. This test analyzes small pieces of DNA circulating in a pregnant woman's blood. NIPT is used to detect chromosomal disorders caused by the presence of an extra or missing copy of a chromosome (aneuploidy). Down syndrome, Edwards’s syndrome, Patau syndrome etc. The test is done using a blood sample which reduces the risk of miscarriage during the test to absolutely zero and has the ability to detect many disorders within 10 weeks of pregnancy, much earlier than any other prenatal diagnostic tests. NIPT has been ranked as the most successful, sensitive, and most accurate test, making it the most preferred test. With increasing percentage of pregnancies among women of advanced age, there is increasing demand for prenatal genetic counseling that helps in predicting the risk of chromosomal abnormalities of the fetus depending on age, thereby fueling the growth of the non-invasive prenatal testing market. The global non-invasive prenatal testing (NIPT) market accounted for US$ 4.3 billion in 2019 and is estimated to be US$ 11.8 billion by 2029 and is anticipated to register a CAGR of 11.9%.

Global Non Invasive Prenatal Testing (NIPT) Market Dynamics

High risk of chromosomal abnormalities with increasing maternal age

Maternal age plays an important role in child health and delay in maternal age can lead to various risks such as reduced fertility, high blood pressure and increased risk of miscarriage, stillbirth and maternal death. Furthermore, increasing maternal age may increase the risk of genetic disorders in babies as a result of improper chromosome segregation. Resulting malformations in babies can include microcephaly; short neck; upper slanting eyes; poor muscle tone; and heart, bowel and respiratory problems. There is a growing demand for early screening of expectant mothers, to detect genetic abnormalities caused by improper chromosome segregation. Hence, non-invasive prenatal testing is the safest one, thus driving the market.

Restraints:

                             Reliability of test results, especially in obese women

A non-invasive prenatal test using maternal blood, which is the source of fetal DNA. However, the amount of fetal fraction in the blood is affected by the mother's weight. It has been reported that the plasma of obese women contains less traces of fetal DNA and therefore may not provide suitable results for analyzing trisomy and other disorders. Thus, non-invasive prenatal testing is not a standardized test. Hence, this factor acts as a restraining factor for the global non-invasive prenatal testing (NIPT) market.

Technological advancement

Advances in modern molecular technology and the discovery of cell-free fetal DNA in maternal plasma have led to new screening methods for fetal chromosomal aneuploidies. With increasing throughput and low cost, NGS technology has paved the way for the detection of chromosomal abnormalities with cffDNA analysis. Growing awareness of the benefits of non-invasive methods has led to a steady increase in the development of advanced technologies for NIPT. Many companies continue to focus on developing highly advanced screening technologies that are highly sensitive and accurate for early detection of genetic disorders in children. Manufacturers are mainly focusing on the development of advanced non-invasive prenatal tests and entering into strategic partnerships and collaborations to strengthen their position in the market.

Global Non Invasive Prenatal Testing (NIPT) Market Segmentation

Source: Prophecy Market Insights

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

The global non-invasive prenatal testing (NIPT) market is segmented based on product type, techniques, application, end-user, and region. Depending upon the product type, the market is segmented into devices, consumables, and others. Based on the techniques, the global non-invasive prenatal testing (NIPT) market is segmented into cfDNA, biochemical screening tests, and ultrasound detection. By application, the market is segmented into trisomy, microdeletion syndrome, and others. The end-user is segmented into diagnostic laboratories, hospitals, and cell DNA screening. The largest share of this application segment is primarily attributed to factors such as increasing incidence of trisomy in babies associated with advancing maternal age in recent years.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On region the Global Non-Invasive Prenatal Testing (NIPT) Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global non-invasive prenatal testing (NIPT) market in terms of revenue due to the increasing availability of the high R&D investment and the availability of technologically advanced healthcare research framework, the development of WGS in the region is also expected to serve as a critical factor for the growth of North America NIPT market throughout the forecast period. Followed by Europe and Asia and the reason being the developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in these regions.

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Billion & CAGR from 2020  to 2030

Market Segmentation

By Product Type - Devices, Consumables, Others

By Techniques - cfDNA, Biochemical Screening Tests, Ultrasound Detection

By Application - Trisomy, Microdeletion syndrome, Others

By End-User - Diagnostic Laboratories, Hospitals, cell DNA screening

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global non-invasive prenatal testing (NIPT) market is segmented based on product type, techniques, application, end-user, and region

Global Non-Invasive Prenatal Testing (NIPT) Market, By Product Type:

  • Devices
  • Consumables
  • Others

Global Non-Invasive Prenatal Testing (NIPT) Market, By Techniques:

  • cfDNA
  • Biochemical Screening Tests
  • Ultrasound Detection

Global Non-Invasive Prenatal Testing (NIPT) Market, By Application:

  • Trisomy
  • Microdeletion syndrome
  • Others

Global Non-Invasive Prenatal Testing (NIPT) Market, By End User:

  • Diagnostic Laboratories
  • Hospitals
  • cell DNA screening

Global Non-Invasive Prenatal Testing (NIPT) Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Non Invasive Prenatal Testing (NIPT) Market Key Players

The key players operating the Global Non-Invasive Prenatal Testing (NIPT) Market includes Sequenom, Roche (Ariosa Diagnostics); Natera, LabCorp, BGI Genomics; Quest Diagnostics, Illumina, Laboratory Corporation of America Holdings, Yourgene Health, and Berry Genomics. For instance, in July 2022, Yourgene Health focused on bolstering its core business to fill COVID-testing void, Manchester genomic testing specialist Yogen Health is set to fill its Covid-testing void by expanding its core offering, linked to further international growth.

Global Non Invasive Prenatal Testing (NIPT) Market Company Profile

  • Sequenom*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Roche (Ariosa Diagnostics)
  • Natera
  • LabCorp
  • BGI Genomics
  • Quest Diagnostics
  • Illumina
  • Laboratory Corporation of America Holdings
  • Yourgene Health
  • Berry Genomics.

 “*” marked represents similar segmentation in other categories in the respective section

Global Non Invasive Prenatal Testing (NIPT) Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Non-Invasive Prenatal Testing (NIPT) Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product Type
      • Market Snippet, By Technique
      • Market Snippet, By Application
      • Market Snippet, By End-User
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Non-Invasive Prenatal Testing (NIPT) Market, By Product Type, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Devices
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Consumables
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  6. Global Non-Invasive Prenatal Testing (NIPT) Market, By Techniques, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • cfDNA
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Biochemical Screening Tests
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Ultrasound Detection
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  7. Global Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Trisomy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Microdeletion syndrome
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  8. Global Non-Invasive Prenatal Testing (NIPT) Market, By End-user, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Diagnostic Laboratories
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Cell DNA screening
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  9. Global Non-Invasive Prenatal Testing (NIPT) Market, By Region, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technique, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technique, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 –2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technique, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technique, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technique, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles
  • Sequenom
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Business Strategies
  • Roche (Ariosa Diagnostics)
  • Natera
  • LabCorp
  • BGI Genomics
  • Quest Diagnostics
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Yourgene Health
  • Berry Genomics
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

 

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market: Product Type Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Product Type

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market, by Product Type 2019-2029 (USD Million)

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market: Techniques Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Techniques

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market, by Techniques 2019-2029 (USD Million)

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market: Application Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Application

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market, by Application 2019-2029 (USD Million)

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market: End-User Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by End-User

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market, by End-User 2019-2029 (USD Million)

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market: Regional snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Non-Invasive Prenatal Testing (NIPT) Market, by Region 2019-2029 (USD Million)

TABLE North America Non-Invasive Prenatal Testing (NIPT) Market, by Country, 2019-2029 (USD Million)

TABLE North America Non-Invasive Prenatal Testing (NIPT) Market, by Product Type, 2019-2029 (USD Million)

TABLE North America Non-Invasive Prenatal Testing (NIPT) Market, by Techniques, 2019-2029 (USD Million)

TABLE North America Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2019-2029 (USD Million)

TABLE North America Non-Invasive Prenatal Testing (NIPT) Market, by End-User 2019-2029 (USD Million)

TABLE Europe Non-Invasive Prenatal Testing (NIPT) Market, by Country, 2019-2029 (USD Million)

TABLE Europe Non-Invasive Prenatal Testing (NIPT) Market, by Product Type, 2019-2029 (USD Million)

TABLE Europe Non-Invasive Prenatal Testing (NIPT) Market, by Techniques, 2019-2029 (USD Million)

TABLE Europe Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2019-2029 (USD Million)

TABLE Europe Non-Invasive Prenatal Testing (NIPT) Market, by End-User, 2019-2029 (USD Million)

TABLE Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market, by Country, 2019-2029 (USD Million)

TABLE Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market, by Product Type, 2019-2029 (USD Million)

TABLE Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market, by Techniques, 2019-2029 (USD Million)

TABLE Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2019-2029 (USD Million)

TABLE Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market, by End-User, 2019-2029 (USD Million)

TABLE Latin America Non-Invasive Prenatal Testing (NIPT) Market, by Country, 2019-2029 (USD Million)

TABLE Latin America Non-Invasive Prenatal Testing (NIPT) Market, by Product Type, 2019-2029 (USD Million)

TABLE Latin America Non-Invasive Prenatal Testing (NIPT) Market, by Techniques, 2019-2029 (USD Million)

TABLE Latin America Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2019-2029 (USD Million)

TABLE Latin America Non-Invasive Prenatal Testing (NIPT) Market, by End-User, 2019-2029 (USD Million)

TABLE Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market, by Country, 2019-2029 (USD Million)

TABLE Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market, by Product Type, 2019-2029 (USD Million)

TABLE Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market, by Techniques, 2019-2029 (USD Million)

TABLE Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2019-2029 (USD Million)

TABLE Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market, by End-User, 2019-2029 (USD Million)

List of Figures

FIGURE Non-Invasive Prenatal Testing (NIPT) Market segmentation

FIGURE Market research methodology

FIGURE Value chain analysis

FIGURE Porter’s Five Forces Analysis

FIGURE Market Attractiveness Analysis

FIGURE COVID-19 Impact Analysis

FIGURE Pre & Post COVID-19 Impact Comparison Study

FIGURE Competitive Landscape; Key company market share analysis, 2019

FIGURE Product Type segment market share analysis, 2019 & 2029

FIGURE Product Type segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Techniques segment market share analysis, 2019 & 2029

FIGURE Techniques segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Application segment market share analysis, 2019 & 2029

FIGURE Application segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE End-User segment market share analysis, 2019 & 2029

FIGURE End-User segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Regional segment market share analysis, 2019 & 2029

FIGURE Regional segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE North America Non-Invasive Prenatal Testing (NIPT) Market share and leading players, 2019

FIGURE Europe Non-Invasive Prenatal Testing (NIPT) Market share and leading players, 2019

FIGURE Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market share and leading players, 2019

FIGURE Latin America Non-Invasive Prenatal Testing (NIPT) Market share and leading players, 2019

FIGURE Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market share and leading players, 2019

FIGURE North America market share analysis by country, 2019

FIGURE U.S. Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Canada Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Europe Non-Invasive Prenatal Testing (NIPT) Market share analysis by country, 2019

FIGURE Germany Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Spain Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Italy Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE UK Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE France Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Rest of the Europe Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market share analysis by country, 2019

FIGURE India Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE China Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Japan Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE South Korea Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Rest of APAC Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Latin America Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Latin America Non-Invasive Prenatal Testing (NIPT) Market share analysis by country, 2019

FIGURE Brazil Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Mexico Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Argentina Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Rest of LATAM Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market share analysis by country, 2019

FIGURE Saudi Arabia Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE United Arab Emirates Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Rest of Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market size, forecast and trend analysis, 2019-2029 (USD Million)

FAQs

The global non-invasive prenatal testing (NIPT) market is segmented based on product type, techniques, application, end-user, and region.

The global non-invasive Prenatal Testing market is projected to grow from $4.11 billion in 2021 to $13.16 billion in 2028 at a CAGR of 18.1%.

North America dominates the global non-invasive prenatal testing (NIPT) market in terms of revenue due to the increasing availability of the high R&D investment and the availability of technologically advanced healthcare research framework, the development of WGS in the region is also expected to serve as a critical factor for the growth of North America NIPT market throughout the forecast period. Followed by Europe.

The key players operating in the non-invasive prenatal testing (NIPT) market include Sequenom, Roche (Ariosa Diagnostics); Natera, LabCorp, BGI Genomics; Quest Diagnostics, Illumina, Laboratory Corporation of America Holdings, Yourgene Health, and Berry Genomics.